DCVC Opportunity Fund II GP, LLC — Q1 2026 13F-HR

← DCVC Opportunity Fund II GP, LLC

Q1 2026 · 13F-HR

DCVC Opportunity Fund II GP, LLCholdings as filed

Filed 2026-05-15 · accession 0001104659-26-062468

$13.9M

Reported value

Positions

2026-03-31

Period end

View analyzed profile →PRO

The Brief · DCVC Opportunity Fund II GP, LLC · Q1 2026

AI · grounded in 13F

DCVC Opportunity Fund II GP, LLC accumulated IONQ, increasing its share count by 532.6%. The fund added one new position to its portfolio. Total assets under management stood at $13.87M across two positions.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
75629V104	RXRX	Recursion Pharmaceuticals, Inc.	$12.1M	87.5%	3,951,141	Common	SOLE
46222L108	IONQ	IonQ, Inc.	$1.7M	12.5%	60,226	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.